Sulphur
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
208 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 9 | 2 | 2 | 14 | 30 |
| Carcinoma | D002277 | — | C80.0 | 1 | 3 | — | 1 | 4 | 8 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | 2 | 1 | 4 | 8 |
| Halitosis | D006209 | — | R19.6 | 1 | 1 | 1 | 1 | 4 | 8 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | 1 | 4 | 5 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | 2 | 1 | 3 |
| Sentinel lymph node biopsy | D021701 | — | — | — | — | — | 1 | 1 | 2 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | — | 1 | 1 | 2 |
| Syndrome | D013577 | — | — | — | — | — | 2 | — | 2 |
| Abdominal injuries | D000007 | — | — | — | — | — | 2 | — | 2 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | 1 | 1 | — | 7 | 9 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 2 | — | 1 | — | 1 | 4 |
| Bronchiolitis | D001988 | — | — | — | 1 | 4 | — | — | 4 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 1 | 2 | — | 1 | 4 |
| Proliferative vitreoretinopathy | D018630 | EFO_1001129 | — | — | 1 | 1 | — | 1 | 3 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | 1 | — | 1 | 3 |
| Obstructive lung diseases | D008173 | — | — | 1 | — | 1 | — | 1 | 3 |
| Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | 2 | 3 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | 1 | 1 | — | 2 | 3 |
| Covid-19 | D000086382 | — | U07.1 | — | — | 2 | — | — | 2 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dissociative disorders | D004213 | — | F44.1 | — | 1 | — | — | 6 | 7 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 3 | — | — | 1 | 4 |
| Lymphedema | D008209 | — | Q82.0 | 2 | 1 | — | — | 1 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 2 | — | — | 2 | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | — | — | 2 | 4 |
| Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | 2 | 4 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 2 | — | — | 1 | 3 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 1 | — | — | 1 | 3 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 1 | — | — | 2 | 3 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 2 |
Show 28 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibrosis | D005355 | — | — | 4 | — | — | — | 3 | 7 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 3 | — | — | — | 2 | 5 |
| Ulcer | D014456 | MPATH_579 | — | 1 | — | — | — | 3 | 4 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | 2 | 3 |
| Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | 2 | 3 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | — | — | — | 1 | 2 |
| Sclerosis | D012598 | — | — | 1 | — | — | — | 1 | 2 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | — | — | — | 1 | 2 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | — | 1 |
| Metabolic side effects of drugs and substances | D065606 | — | — | 1 | — | — | — | — | 1 |
Show 21 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | — | — | — | — | 6 | 6 |
| Retinal perforations | D012167 | EFO_1001028 | — | — | — | — | — | 4 | 4 |
| Microcirculation | D008833 | — | — | — | — | — | — | 3 | 3 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 3 | 3 |
| Melanoma | D008545 | — | — | — | — | — | — | 2 | 2 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | — | — | — | — | 2 | 2 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 2 | 2 |
| Fuchs' endothelial dystrophy | D005642 | EFO_0003946 | H18.51 | — | — | — | — | 2 | 2 |
| Rectal neoplasms | D012004 | — | — | — | — | — | — | 2 | 2 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 2 | 2 |
Show 87 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
42 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use